SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
THOMAS H. LEE ADVISORS, LLC

(Last) (First) (Middle)
C/O THOMAS H. LEE PARTNERS, L.P.
100 FEDERAL STREET, 35TH FLOOR

(Street)
BOSTON MA 02110

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Syneos Health, Inc. [ SYNH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/09/2018
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 08/09/2018 S 6,000,000 D $49.73 19,239,664 I See footnote(1)(2)(3)(4)
Class A Common Stock 12,562 D(5)(6)(7)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
THOMAS H. LEE ADVISORS, LLC

(Last) (First) (Middle)
C/O THOMAS H. LEE PARTNERS, L.P.
100 FEDERAL STREET, 35TH FLOOR

(Street)
BOSTON MA 02110

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Thomas H. Lee Equity Fund VI, L.P.

(Last) (First) (Middle)
C/O THOMAS H. LEE PARTNERS, L.P.
100 FEDERAL STREET, 35TH FLOOR

(Street)
BOSTON MA 02110

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Thomas H. Lee Parallel (DT) Fund VI, L.P.

(Last) (First) (Middle)
C/O THOMAS H. LEE PARTNERS, L.P.
100 FEDERAL STREET, 35TH FLOOR

(Street)
BOSTON MA 02110

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Thomas H. Lee Parallel Fund VI, L.P.

(Last) (First) (Middle)
C/O THOMAS H. LEE PARTNERS, L.P.
100 FEDERAL STREET, 35TH FLOOR

(Street)
BOSTON MA 02110

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Thomas H. Lee Equity Fund VII, L.P.

(Last) (First) (Middle)
C/O THOMAS H. LEE PARTNERS, L.P.
100 FEDERAL STREET, 35TH FLOOR

(Street)
BOSTON MA 02110

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Thomas H. Lee Parallel Fund VII, L.P.

(Last) (First) (Middle)
C/O THOMAS H. LEE PARTNERS, L.P.
100 FEDERAL STREET, 35TH FLOOR

(Street)
BOSTON MA 02110

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Thomas H. Lee Parallel (Cayman) Fund VII, L.P.

(Last) (First) (Middle)
C/O THOMAS H. LEE PARTNERS, L.P.
100 FEDERAL STREET, 35TH FLOOR

(Street)
BOSTON MA 02110

(City) (State) (Zip)
1. Name and Address of Reporting Person*
ABBRECHT TODD M

(Last) (First) (Middle)
C/O THOMAS H. LEE PARTNERS, L.P.
100 FEDERAL STREET, 35TH FLOOR

(Street)
BOSTON MA 02110

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Nelson Joshua M

(Last) (First) (Middle)
C/O THOMAS H. LEE PARTNERS, L.P.
100 FEDERAL STREET, 35TH FLOOR

(Street)
BOSTON MA 02110

(City) (State) (Zip)
Explanation of Responses:
1. See Exhibit 99.1 for text of footnote (1).
2. See Exhibit 99.1 for text of footnote (2).
3. See Exhibit 99.1 for text of footnote (3).
4. See Exhibit 99.1 for text of footnote (4).
5. See Exhibit 99.1 for text of footnote (5).
6. See Exhibit 99.1 for text of footnote (6).
7. See Exhibit 99.1 for text of footnote (7).
Remarks:
Exhibit 99.1 and Exhibit 99.2 (Joint Filer Information) are incorporated herein by reference. This Form 4 is the first of two Forms 4 being filed relating to the same event. The Form 4 has been split into two filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 Reporting Persons. Each Form 4 will be filed by Designated Filer Thomas H. Lee Advisors, LLC.
Thomas H. Lee Advisors, LLC By: THL Holdco, LLC, its Managing Member By: /s/ Charles P. Holden Title: Managing Director 08/13/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Exhibit 99.1

Name and Address of Reporting Person:
Thomas H. Lee Advisors, LLC
 
c/o Thomas H. Lee Partners, L.P.
 
100 Federal Street, 35th Floor
 
Boston, MA 02210
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
 
be Reported:
August 9, 2018
(Month/Day/Year)
 

Footnotes to Form 4

(1) The shares of the Issuer reported are beneficially owned by: Thomas H. Lee Advisors, LLC (“THL Advisors”),Thomas H. Lee Equity Fund VI, L.P. (“Equity Fund VI”); Thomas H. Lee Parallel (DT) Fund VI, L.P. (“(DT) Fund VI”); Thomas H. Lee Parallel Fund VI, L.P. (“Parallel Fund VI”); Thomas H. Lee Equity Fund VII, L.P. (“Equity Fund VII”); Thomas H. Lee Parallel Fund VII, L.P.  (“Parallel Fund VII”); Thomas H. Lee Parallel (Cayman) Fund VII, L.P. (“Parallel (Cayman) Fund VII”); THL Executive Fund VII (“Executive Fund VII”); THL Equity Fund VII Investors (inVentiv), L.P. (“Equity Fund VII (inVentiv)”); THL Fund VII Coinvestment Partners, L.P. (“Fund VII Coinvest”); THL Coinvestment Partners, L.P. (“Coinvest Partners”); THL Operating Partners, L.P. (“THL Operating Partners”); Great-West Investors, L.P. (“Great-West Investors”); Putnam Investments Employees’ Securities Company III, LLC (“Putnam III”) (collectively with their affiliates, the “THL Funds”); Todd M. Abbrecht; and Joshua M. Nelson.

(2) THL Advisors is the general partner of Thomas H. Lee Partners, L.P. (“THL”), which in turn is the sole member of THL Equity Advisors VI, LLC (“Equity Advisors VI”), the sole member of THL Equity Advisors VII, LLC (“Equity Advisors VII”), the general partner of THL Operating Partners, the general partner of Fund VII Coinvest, and the general partner of Coinvest Partners. Equity Advisors VI is the general partner of Equity Fund VI, (DT) Fund VI, and Parallel Fund VI. Equity Advisors VII is the general partner of Equity Fund VII, Parallel Fund VII, Parallel (Cayman) Fund VII, Executive Fund VII, and Equity Fund VII (inVentiv). THL Advisors is the attorney-in-fact of Great-West Investors and Putnam Investments, LLC. Putnam Investments, LLC is the managing member of Putnam Investments Holdings, LLC, which in turn is the managing member of Putnam III.

(3) Each Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest.

(4) Represents shares of the Issuer directly held by the following entities following the transaction: 3,029,630 shares of common stock held by Equity Fund VI, 2,051,504 shares of common stock held by Parallel Fund VI, 358,357 shares of common stock held by Parallel (DT) Fund VI, 28,433 shares of common stock held by Coinvestment Partners, 5,399 shares of common stock held by THL Operating Partners, 15,515 shares of common stock held by Great-West Investors, 15,502 shares of common stock held by Putnam III LLC, 1,429,259 shares of common stock held by Equity Fund VII, 1,127,743 shares of common stock held by Parallel Fund VII, 1,511,529 shares of common stock held by Parallel (Cayman) Fund VII, L.P., 125,282 shares of common stock held by Executive Fund VII, 217,962 shares of common stock held by Fund VII Coinvest and 9,323,549 shares of common stock held by Equity Fund VII (inVentiv).

(5) Represents 6,281 RSUs awarded to Mr. Abbrecht and 6,281 RSUs awarded to Mr. Nelson, in each case, as compensation for their service on the Board of Directors of the Issuer.

(6) Todd M. Abbrecht is a Managing Director of THL.  Pursuant to the operative agreements among certain of the THL Funds, any securities issued to persons serving as directors of portfolio companies of the THL Funds, such as the Issuer, are to be held for the benefit of the THL Funds.

(7)  Joshua M. Nelson is a Managing Director of THL.  Pursuant to the operative agreements among certain of the THL Funds, any securities issued to persons serving as directors of portfolio companies of the THL Funds, such as the Issuer, are to be held for the benefit of the THL Funds.
 
 


Exhibit 99.2

Joint Filer Information
 
Name of Joint Filer:
Thomas H. Lee Equity Fund VI, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.
100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
 
be Reported:
August 9, 2018
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THOMAS H. LEE EQUITY FUND VI, L.P.
By: THL Equity Advisors VI, LLC, its General Partner
By: Thomas H. Lee Partners, L.P., its Sole Member
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member
 
By:
/s/ Charles P. Holden  
Name:
Charles P. Holden
 
Title:
Managing Director
 
     
Dated:
August 13, 2018
 
 
Page 1 of 15

Exhibit 99.2

Joint Filer Information
 
Name of Joint Filer:
Thomas H. Lee Parallel (DT) Fund VI, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.
 
100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
 
be Reported:
August 9, 2018
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THOMAS H. LEE PARALLEL (DT) FUND VI, L.P.
By: THL Equity Advisors VI, LLC, its General Partner
By: Thomas H. Lee Partners, L.P., its Sole Member
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member
 
By:
/s/ Charles P. Holden  
Name:
Charles P. Holden
 
Title:
Managing Director
 
     
Dated:
August 13, 2018
 
 
Page 2 of 15

Exhibit 99.2

Joint Filer Information
 
Name of Joint Filer:
Thomas H. Lee Parallel Fund VI, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.
100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
 
be Reported:
August 9, 2018
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THOMAS H. LEE PARALLEL FUND VI, L.P.
By: THL Equity Advisors VI, LLC, its General Partner
By: Thomas H. Lee Partners, L.P., its Sole Member
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member
 
By:
/s/ Charles P. Holden  
Name:
Charles P. Holden
 
Title:
Managing Director
 
     
Dated:
August 13, 2018
 
 
Page 3 of 15

Exhibit 99.2

Joint Filer Information
 
Name of Joint Filer:
Thomas H. Lee Equity Fund VII, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.
100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
 
be Reported:
August 9, 2018
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THOMAS H. LEE EQUITY FUND VII, L.P.
By: THL Equity Advisors VII, LLC, its General Partner
By: Thomas H. Lee Partners, L.P., its Sole Member
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member
 
By:
/s/ Charles P. Holden  
Name:
Charles P. Holden
 
Title:
Managing Director
 
     
Dated:
August 13, 2018
 
 
Page 4 of 15

Exhibit 99.2

Joint Filer Information
 
Name of Joint Filer:
Thomas H. Lee Parallel Fund VII, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.
100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
 
be Reported:
August 9, 2018
   
Designated Filer:
Thomas H. Lee Advisors, LLC
 
Signature:

THOMAS H. LEE PARALLEL FUND VII, L.P.
By: THL Equity Advisors VII, LLC, its General Partner
By: Thomas H. Lee Partners, L.P., its Sole Member
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member
 
By:
/s/ Charles P. Holden  
Name:
Charles P. Holden
 
Title:
Managing Director
 
     
Dated:
August 13, 2018
 
 
Page 5 of 15

Exhibit 99.2

Joint Filer Information
 
Name of Joint Filer:
Thomas H. Lee Parallel (Cayman) Fund VII, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.
 
100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
 
be Reported:
August 9, 2018
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THOMAS H. LEE PARALLEL (CAYMAN) FUND VII, L.P.
By: THL Equity Advisors VII, LLC, its General Partner
By: Thomas H. Lee Partners, L.P., its Sole Member
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member
 
By:
/s/ Charles P. Holden  
Name:
Charles P. Holden
 
Title:
Managing Director
 
     
Dated:
August 13, 2018
 
 
Page 6 of 15

Exhibit 99.2

Joint Filer Information
 
Name of Joint Filer:
Todd M. Abbrecht
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.
 
100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of the Earliest Transaction
 
Required to be Reported (Month/Day/Year):
August 9, 2018
   
Designated Filer:
Thomas H. Lee Advisors, LLC
 
Signature:
 
By:
/s/ Todd M. Abbrecht  
Name:
Todd M. Abbrecht
 
     
Dated:
August 13, 2018
 
 
Page 7 of 15

Exhibit 99.2

Joint Filer Information
 
Name of Joint Filer:
Joshua M. Nelson
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.
 
100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of the Earliest Transaction
 
Required to be Reported (Month/Day/Year):
August 9, 2018
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:
 
By:
/s/ Joshua M. Nelson  
Name:
Joshua M. Nelson
 
     
Dated:
August 13, 2018
 
 
Page 8 of 15

Exhibit 99.2

Joint Filer Information
 
Name of Joint Filer:
THL Fund VII Coinvestment Partners, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.
 
100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of the Earliest Transaction
 
Required to be Reported (Month/Day/Year):
August 9, 2018
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THL FUND VII COINVESTMENT PARTNERS, L.P.
By: Thomas H. Lee Partners, L.P., its General Partner
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member
 
By:
/s/ Charles P. Holden  
Name:
Charles P. Holden
 
Title:
Managing Director
 
     
Dated:
August 13, 2018
 
 
Page 9 of 15

 Exhibit 99.2

Joint Filer Information
 
Name of Joint Filer:
THL Coinvestment Partners, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.
 
100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of the Earliest Transaction
 
Required to be Reported (Month/Day/Year):
August 9, 2018
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THL COINVESTMENT PARTNERS, L.P.
By: Thomas H. Lee Partners, L.P., its General Partner
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member
 
By:
/s/ Charles P. Holden  
Name:
Charles P. Holden
 
Title:
Managing Director
 
     
Dated:
August 13, 2018
 
 
Page 10 of 15

Exhibit 99.2

Joint Filer Information
 
Name of Joint Filer:
THL Operating Partners, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.
100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of the Earliest Transaction
 
Required to be Reported (Month/Day/Year):
August 9, 2018
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THL OPERATING PARTNERS, L.P.
By: Thomas H. Lee Partners, L.P., its General Partner
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member
 
By:
/s/ Charles P. Holden  
Name:
Charles P. Holden
 
Title:
Managing Director
 
     
Dated:
August 13, 2018
 
 
Page 11 of 15

Exhibit 99.2

Joint Filer Information
 
Name of Joint Filer:
Great-West Investors, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.
100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of the Earliest Transaction
 
Required to be Reported (Month/Day/Year):
August 9, 2018
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

GREAT-WEST INVESTORS, L.P.
By: Thomas H. Lee Advisors, LLC, its Attorney-in-Fact
By: THL Holdco, LLC, its Managing Member
 
By:
/s/ Charles P. Holden  
Name:
Charles P. Holden
 
Title:
Managing Director
 
     
Dated:
August 13, 2018
 
 
Page 12 of 15

Exhibit 99.2

Joint Filer Information
 
Name of Joint Filer:
Putnam Investments Employees’ Securities Company III, LLC
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.
100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of the Earliest Transaction
 
Required to be Reported (Month/Day/Year):
August 9, 2018
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

PUTNAM INVESTMENTS EMPLOYEES’ SECURITIES COMPANY III, LLC
By: Putnam Investments Holdings, LLC, its Managing Member
By: Putnam Investments, LLC, its Managing Member
By: Thomas H. Lee Advisors, LLC, its Attorney-in-Fact
By: THL Holdco, LLC, its Managing Member
 
By:
/s/ Charles P. Holden  
Name:
Charles P. Holden
 
Title:
Managing Director
 
     
Dated:
August 13, 2018
 
 
Page 13 of 15

Exhibit 99.2

Joint Filer Information
 
Name of Joint Filer:
THL Executive Fund VII, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.
100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
 
be Reported:
August 9, 2018
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THL EXECUTIVE FUND VII, L.P.
By: THL Equity Advisors VII, LLC, its General Partner
By: Thomas H. Lee Partners, L.P., its Sole Member
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member
 
By:
/s/ Charles P. Holden  
Name:
Charles P. Holden
 
Title:
Managing Director
 
     
Dated:
August 13, 2018
 
 
Page 14 of 15

Exhibit 99.2

Joint Filer Information
 
Name of Joint Filer:
THL Equity Fund VII Investors (inVentiv), L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.
100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
 
be Reported:
August 9, 2018
   
Designated Filer:
Thomas H. Lee Advisors, LLC
   
Signature:

THL EQUITY FUND VII INVESTORS (INVENTIV), L.P.
By: THL Equity Advisors VII, LLC, its General Partner
By: Thomas H. Lee Partners, L.P., its Sole Member
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member
 
By:
/s/ Charles P. Holden  
Name:
Charles P. Holden
 
Title:
Managing Director
 
     
Dated:
August 13, 2018
 
 
 
Page 15 of 15